Shu‐Guang Zhou

Area of research

Pathology and Forensic Medicine · Oncology

Research interest

Research interests include Mantle cell lymphoma, Lenalidomide, Medicine, Rituximab, Phases of clinical research, and Internal medicine.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

48 | NOVEL TRIPLET COMBINATION OF ORELABRUTINIB, LENALIDOMIDE, AND RITUXIMAB AS FRONTLINE THERAPY FOR MANTLE CELL LYMPHOMA: FINAL RESULTS OF POLARIS MULTICENTER PHASE II STUDY

Hematological Oncology 2025cited by 1position: middledoi

ORELABRUTINIB‐LENALIDOMIDE‐RITUXIMAB (OLR) IN PATIENTS WITH UNTREATED MANTLE CELL LYMPHOMA (MCL): A PROSPECTIVE, MULTICENTER, SINGLE‐ARM PHASE 2 POLARIS STUDY IN CHINA

Hematological Oncology 2023cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pathology and Forensic Medicine · Oncology →